Steven C. Clifford

27.1k total citations · 6 hit papers
132 papers, 13.8k citations indexed

About

Steven C. Clifford is a scholar working on Molecular Biology, Genetics and Cancer Research. According to data from OpenAlex, Steven C. Clifford has authored 132 papers receiving a total of 13.8k indexed citations (citations by other indexed papers that have themselves been cited), including 88 papers in Molecular Biology, 56 papers in Genetics and 43 papers in Cancer Research. Recurrent topics in Steven C. Clifford's work include Glioma Diagnosis and Treatment (56 papers), Hedgehog Signaling Pathway Studies (32 papers) and Epigenetics and DNA Methylation (32 papers). Steven C. Clifford is often cited by papers focused on Glioma Diagnosis and Treatment (56 papers), Hedgehog Signaling Pathway Studies (32 papers) and Epigenetics and DNA Methylation (32 papers). Steven C. Clifford collaborates with scholars based in United Kingdom, United States and Germany. Steven C. Clifford's co-authors include Eamonn R. Maher, Peter J. Ratcliffe, Patrick H. Maxwell, Gin-Wen Chang, Christopher W. Pugh, Matthew E. Cockman, Michael S. Wiesener, Charles C. Wykoff, David W. Ellison and Richard J. Gilbertson and has published in prestigious journals such as Nature, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Steven C. Clifford

129 papers receiving 13.6k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis

1999 4.2k citations Steven C. Clifford et al. profile →
Molecular subgroups of medulloblastoma: the current consensus

2011 1.2k citations Michael D. Taylor, Paul A. Northcott et al. Acta Neuropathologica profile →
Hypoxia Inducible Factor-α Binding and Ubiquitylation by the von Hippel-Lindau Tumor Suppressor Protein

2000 893 citations Steven C. Clifford et al. profile →
Medulloblastoma Comprises Four Distinct Molecular Variants

2010 886 citations Paul A. Northcott, Andrey Korshunov et al. Journal of Clinical Oncology profile →
Medulloblastoma

2019 384 citations Paul A. Northcott, Steven C. Clifford et al. profile →
Novel molecular subgroups for clinical classification and outcome prediction in childhood medulloblastoma: a cohort study

2017 338 citations Ed C. Schwalbe, Janet C. Lindsey et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Steven C. Clifford United Kingdom	47	9.4k	6.0k	4.3k	1.8k	1.7k	132	13.8k
Hai Yan United States	37	7.1k 0.8×	4.6k 0.8×	5.5k 1.3×	2.2k 1.3×	2.0k 1.2×	91	12.5k
William A. Weiss United States	60	9.3k 1.0×	3.7k 0.6×	2.6k 0.6×	2.8k 1.6×	1.9k 1.1×	268	15.3k
Georg Breier Germany	58	12.0k 1.3×	5.2k 0.9×	1.6k 0.4×	2.9k 1.7×	1.4k 0.8×	114	17.6k
J Costello United States	48	7.8k 0.8×	2.8k 0.5×	1.9k 0.4×	1.5k 0.8×	773 0.5×	142	10.6k
V. Peter Collins Sweden	57	4.4k 0.5×	2.2k 0.4×	4.3k 1.0×	1.7k 1.0×	1.6k 0.9×	155	10.1k
Josef T. Prchal United States	52	5.1k 0.5×	2.6k 0.4×	4.5k 1.1×	878 0.5×	1.5k 0.9×	387	13.1k
Brian Keith United States	44	7.5k 0.8×	6.8k 1.1×	989 0.2×	3.4k 1.9×	1.3k 0.8×	65	13.7k
Zhengping Zhuang United States	63	4.9k 0.5×	4.0k 0.7×	1.0k 0.2×	2.8k 1.6×	1.5k 0.9×	321	12.3k
Monica Nistér Sweden	50	5.5k 0.6×	1.9k 0.3×	1.7k 0.4×	2.4k 1.3×	772 0.5×	160	9.1k
Andreas Trumpp Germany	62	9.1k 1.0×	3.0k 0.5×	2.1k 0.5×	4.7k 2.6×	1.2k 0.7×	201	17.4k

Countries citing papers authored by Steven C. Clifford

Since Specialization

Citations

This map shows the geographic impact of Steven C. Clifford's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven C. Clifford with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven C. Clifford more than expected).

Fields of papers citing papers by Steven C. Clifford

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven C. Clifford. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven C. Clifford. The network helps show where Steven C. Clifford may publish in the future.

Co-authorship network of co-authors of Steven C. Clifford

This figure shows the co-authorship network connecting the top 25 collaborators of Steven C. Clifford. A scholar is included among the top collaborators of Steven C. Clifford based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steven C. Clifford. Steven C. Clifford is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Davies, Simon, Vijay Ramaswamy, Ed C. Schwalbe, et al.. (2024). The clinical significance of sub-total surgical resection in childhood medulloblastoma: a multi-cohort analysis of 1100 patients. EClinicalMedicine. 69. 102469–102469. 4 indexed citations

Bailey, Simon, Sandra Jacobs, Maria Kourti, et al.. (2024). Medulloblastoma therapy: Consensus treatment recommendations from SIOP-Europe and the European Reference Network. SHILAP Revista de lepidopterología. 5. 100205–100205. 1 indexed citations

Bailey, Simon, Alan Davidson, Jeannette Parkes, et al.. (2022). How Can Genomic Innovations in Pediatric Brain Tumors Transform Outcomes in Low- and Middle-Income Countries?. JCO Global Oncology. 8(8). e2200156–e2200156. 12 indexed citations

Chen, Zhuoyao, Stacey Richardson, Iolanda Vendrell, et al.. (2022). Disease-associated KBTBD4 mutations in medulloblastoma elicit neomorphic ubiquitylation activity to promote CoREST degradation. Cell Death and Differentiation. 29(10). 1955–1969. 17 indexed citations

Badodi, Sara, Nicola Pomella, Xinyu Zhang, et al.. (2021). Inositol treatment inhibits medulloblastoma through suppression of epigenetic-driven metabolic adaptation. Nature Communications. 12(1). 2148–2148. 19 indexed citations

Hill, Rebecca M., Sabine Plasschaert, Beate Timmermann, et al.. (2021). Relapsed Medulloblastoma in Pre-Irradiated Patients: Current Practice for Diagnostics and Treatment. Cancers. 14(1). 126–126. 14 indexed citations

Hanna, Rita, Jérôme Durivault, Fanny Burel‐Vandenbos, et al.. (2020). VEGFC negatively regulates the growth and aggressiveness of medulloblastoma cells. Communications Biology. 3(1). 579–579. 12 indexed citations

Ramaswamy, Vijay, Marcel Kool, Brigitta Stockinger, et al.. (2020). The AHR pathway represses TGFβ-SMAD3 signalling and has a potent tumour suppressive role in SHH medulloblastoma. Scientific Reports. 10(1). 148–148. 20 indexed citations

Mynarek, Martin, Torsten Pietsch, Stefan M. Pfister, et al.. (2019). Imaging Characteristics of Wingless Pathway Subgroup Medulloblastomas: Results from the German HIT/SIOP-Trial Cohort. American Journal of Neuroradiology. 40(11). 1811–1817. 8 indexed citations

10.

Sabel, Magnus, Gudrun Fleischhack, Stephan Tippelt, et al.. (2016). Relapse patterns and outcome after relapse in standard risk medulloblastoma: a report from the HIT-SIOP-PNET4 study. Journal of Neuro-Oncology. 129(3). 515–524. 78 indexed citations

11.

Schwalbe, Ed C., Daniel Williamson, Janet C. Lindsey, et al.. (2013). DNA methylation profiling of medulloblastoma allows robust subclassification and improved outcome prediction using formalin-fixed biopsies. Acta Neuropathologica. 125(3). 359–371. 103 indexed citations

12.

Schwalbe, Ed C., Janet C. Lindsey, Twala L. Hogg, et al.. (2011). Rapid Diagnosis of Medulloblastoma Molecular Subgroups. Clinical Cancer Research. 17(7). 1883–1894. 58 indexed citations

13.

Menghi, Francesca, Thomas S. Jacques, Martino Barenco, et al.. (2011). Genome-Wide Analysis of Alternative Splicing in Medulloblastoma Identifies Splicing Patterns Characteristic of Normal Cerebellar Development. Cancer Research. 71(6). 2045–2055. 18 indexed citations

14.

Ellison, David W., Mehmet Koçak, James Dalton, et al.. (2010). Definition of Disease-Risk Stratification Groups in Childhood Medulloblastoma Using Combined Clinical, Pathologic, and Molecular Variables. Journal of Clinical Oncology. 29(11). 1400–1407. 203 indexed citations

15.

Northcott, Paul A., Andrey Korshunov, Hendrik Witt, et al.. (2010). Medulloblastoma Comprises Four Distinct Molecular Variants. Journal of Clinical Oncology. 29(11). 1408–1414. 886 indexed citations breakdown →

16.

Rozanska, Agata, Huw D. Thomas, Evan A. Mulligan, et al.. (2009). Inhibition of Poly(ADP-Ribose) Polymerase-1 Enhances Temozolomide and Topotecan Activity against Childhood Neuroblastoma. Clinical Cancer Research. 15(4). 1241–1249. 61 indexed citations

17.

Ellison, David W., Janet C. Lindsey, Meryl E. Lusher, et al.. (2005). β-Catenin Status Predicts a Favorable Outcome in Childhood Medulloblastoma: The United Kingdom Children's Cancer Study Group Brain Tumour Committee. Journal of Clinical Oncology. 23(31). 7951–7957. 290 indexed citations

18.

Lindsey, Janet C., Meryl E. Lusher, Gordon Strathdee, et al.. (2005). Epigenetic inactivation ofMCJ (DNAJD1) in malignant paediatric brain tumours. International Journal of Cancer. 118(2). 346–352. 47 indexed citations

19.

Lusher, Meryl E., Janet C. Lindsey, Farida Latif, et al.. (2002). Biallelic epigenetic inactivation of the RASSF1A tumor suppressor gene in medulloblastoma development.. PubMed. 62(20). 5906–11. 63 indexed citations

20.

Clifford, Steven C., David E. Neal, & John Lunec. (1996). Alterations in expression of the multidrug resistance-associated protein (MRP) gene in high-grade transitional cell carcinoma of the bladder. British Journal of Cancer. 73(5). 659–666. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact